EXPRESS-ZERTIFIKAT - ZURICH INSURANCE/SWISS RE/ROCHE GS Share Price

Certificat

DE000SH9ZFK6

Market Closed - Deutsche Boerse AG 08:24:06 27/05/2024 pm IST
100.8 EUR -0.06% Intraday chart for EXPRESS-ZERTIFIKAT - ZURICH INSURANCE/SWISS RE/ROCHE GS
Current month+2.07%
1 month+2.17%
Date Price Change
27/24/27 100.8 -0.06%
24/24/24 100.8 -0.26%
23/24/23 101.1 +0.23%
22/24/22 100.9 -0.29%
21/24/21 101.2 -0.16%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 08:24 pm IST

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SH9ZFK
ISINDE000SH9ZFK6
Date issued 03/08/2023
Strike 267 CHF
Maturity 03/02/2025 (252 Days)
Parity 0.27 : 1
Emission price 1,000
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 103.2
Lowest since issue 96.92

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
229.9 CHF
Average target price
279.8 CHF
Spread / Average Target
+21.72%
Consensus